Aviva PLC Nevro Corp Transaction History

Aviva PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$141.6 - $179.06 $1.22 Million - $1.54 Million	-8,598 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$132.81 - $182.18 $16,202 - $22,225	-122 Reduced 1.4%	8,598 $1.2 Million
Q4 2020 Feb 10, 2021	SELL	$138.17 - $184.34 $976,861 - $1.3 Million	-7,070 Reduced 44.78%	8,720 $1.51 Million
Q3 2020 Nov 12, 2020	SELL	$114.09 - $145.51 $404,791 - $516,269	-3,548 Reduced 18.35%	15,790 $2.2 Million
Q2 2020 Aug 13, 2020	BUY	$89.45 - $129.85 $1.73 Million - $2.51 Million	19,338 New	19,338 $2.31 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.